You are here
Clinical Trials: Vascular Disease
Each Clinical Trial will open in a new browser window or tab.
Condition: Diabetic Foot Ulcer
Interventions: Biological: ALLO-ASC-DFU; Procedure: Vehicle Sheet
Sponsor: Anterogen Co., Ltd.
Recruiting
Interventions: Biological: ALLO-ASC-DFU; Procedure: Vehicle Sheet
Sponsor: Anterogen Co., Ltd.
Recruiting
Conditions: Cardiovascular Diseases; Cardiovascular Risk Factor; Triglycerides High; Diabetes Mellitus, Type 2
Intervention: Drug: Icosapent Ethyl 1000 MG Oral Capsule [Vascepa]
Sponsors: Canadian Medical and Surgical Knowledge Translation Research Group; HLS Therapeutics, Inc; St. Michael's Hospital, Toronto; University of Western Ontario, Canada
Not yet recruiting
Intervention: Drug: Icosapent Ethyl 1000 MG Oral Capsule [Vascepa]
Sponsors: Canadian Medical and Surgical Knowledge Translation Research Group; HLS Therapeutics, Inc; St. Michael's Hospital, Toronto; University of Western Ontario, Canada
Not yet recruiting
Condition: Acute Myocardial Infarction
Interventions: Biological: Intravenous infusion placebo; Biological: Intravenous infusion WJMSCs
Sponsors: Navy General Hospital, Beijing; Peking University Third Hospital; Peking Union Medical College Hospital; Xijing Hospital; Chinese PLA General Hospital
Not yet recruiting
Interventions: Biological: Intravenous infusion placebo; Biological: Intravenous infusion WJMSCs
Sponsors: Navy General Hospital, Beijing; Peking University Third Hospital; Peking Union Medical College Hospital; Xijing Hospital; Chinese PLA General Hospital
Not yet recruiting
Condition: Coronary Artery Disease
Intervention: Biological: Intravenous infusion human umbilical Wharton's jelly-derived mesenchymal stem Cell or placebo PBS
Sponsors: Navy General Hospital, Beijing; Chinese PLA General Hospital; Peking University Third Hospital; Peking Union Medical College Hospital; Xijing Hospital
Not yet recruiting
Intervention: Biological: Intravenous infusion human umbilical Wharton's jelly-derived mesenchymal stem Cell or placebo PBS
Sponsors: Navy General Hospital, Beijing; Chinese PLA General Hospital; Peking University Third Hospital; Peking Union Medical College Hospital; Xijing Hospital
Not yet recruiting
Conditions: Heated Tobacco Products; Microcirculation; Thrombosis; Vascular Function; Blood Markers; Microvesicles; NETs
Intervention: Other: HTP inhalation
Sponsor: Karolinska Institutet
Recruiting
Intervention: Other: HTP inhalation
Sponsor: Karolinska Institutet
Recruiting
Condition: Diabetic Foot Ulcer
Intervention: Biological: ALLO-ASC-SHEET
Sponsor: Anterogen Co., Ltd.
Not yet recruiting
Intervention: Biological: ALLO-ASC-SHEET
Sponsor: Anterogen Co., Ltd.
Not yet recruiting
Condition: Ischemic Stroke
Intervention: Other: Autologous transplant
Sponsor: Centre Hospitalier Universitaire Vaudois
Not yet recruiting
Intervention: Other: Autologous transplant
Sponsor: Centre Hospitalier Universitaire Vaudois
Not yet recruiting
Conditions: Limb Ischemia; Diabetic Foot
Interventions: Drug: High dose allogeneic mesenchymal stromal cells; Drug: Low dose allogeneic mesenchymal stromal cells; Drug: Placebos
Sponsor: Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz
Not yet recruiting
Interventions: Drug: High dose allogeneic mesenchymal stromal cells; Drug: Low dose allogeneic mesenchymal stromal cells; Drug: Placebos
Sponsor: Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz
Not yet recruiting
Condition: Diabetic Foot Ulcer
Interventions: Other: Single dose experiments; Other: Multi-dose experiments
Sponsor: Beijing Tongren Hospital
Not yet recruiting
Interventions: Other: Single dose experiments; Other: Multi-dose experiments
Sponsor: Beijing Tongren Hospital
Not yet recruiting
Conditions: Stroke; Hemiparesis;Poststroke/CVA (Cerebrovascular Accident)
Intervention: Device: MyHand Device
Sponsors: Columbia University; National Institute of Neurological Disorders and Stroke (NINDS)
Not yet recruiting
Intervention: Device: MyHand Device
Sponsors: Columbia University; National Institute of Neurological Disorders and Stroke (NINDS)
Not yet recruiting
